Pulse Biosciences, Inc.
(NASDAQ : PLSE)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
-1.98%78.120.6%$389.89m
TMOThermo Fisher Scientific Inc.
-1.04%186.351.0%$271.73m
ABTAbbott Laboratories
0.01%52.520.8%$259.42m
ISRGIntuitive Surgical, Inc.
-1.42%1016.927.5%$249.64m
BDXBecton, Dickinson and Company
0.03%193.121.3%$208.05m
SYKStryker Corporation
-0.87%139.661.3%$157.87m
ALGNAlign Technology, Inc.
-1.86%184.516.2%$153.63m
COOCooper Companies, Inc.
-0.10%239.522.2%$146.02m
EWEdwards Lifesciences Corporation
-0.55%110.031.2%$138.85m
BAXBaxter International Inc.
-1.27%62.711.7%$137.50m
BSXBoston Scientific Corporation
-0.47%28.721.1%$134.34m
ZBHZimmer Biomet Holdings, Inc.
-0.45%113.891.7%$128.23m
BCRC. R. Bard, Inc.
-0.04%318.511.6%$117.51m
HOLXHologic, Inc.
-0.59%37.351.6%$116.54m
XRAYDENTSPLY International Inc.
0.80%59.003.0%$110.63m

Company Profile

Pulse Biosciences, Inc. is a development stage medical device company. It manufactures surgical and medical instruments uses a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells. The company was founded on May 19, 2014 and is headquartered in Burlingame, CA.